Pierangelo Geppetti Selected Research

Tryptamines (Triptans)

1/2022	Galcanezumab effectiveness on comorbid cluster headache and chronic migraine: a prospective case series.
10/2010	Chronic headaches and medication overuse.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierangelo Geppetti Research Topics

Disease

46	Migraine Disorders (Migraine) 03/2024 - 04/2005
46	Pain (Aches) 01/2023 - 11/2006
30	Hyperalgesia 04/2023 - 05/2004
20	Inflammation (Inflammations) 01/2020 - 11/2002
17	Neurogenic Inflammation 01/2023 - 04/2004
16	Headache (Headaches) 01/2023 - 02/2012
13	Neuralgia (Stump Neuralgia) 01/2023 - 10/2010
12	Melanoma (Melanoma, Malignant) 11/2021 - 06/2005
11	Neoplasms (Cancer) 10/2023 - 02/2006
7	Hypersensitivity (Allergy) 01/2020 - 08/2007
7	Asthma (Bronchial Asthma) 04/2014 - 01/2002
6	Cough 06/2015 - 08/2006
6	Chronic Obstructive Pulmonary Disease (COPD) 04/2014 - 01/2003
4	Prescription Drug Overuse 01/2023 - 11/2018
4	Peripheral Nervous System Diseases (PNS Diseases) 01/2023 - 09/2006
4	Cancer Pain 01/2022 - 01/2019
4	Cold Hypersensitivity 12/2020 - 07/2011
3	Epilepsy (Aura) 01/2023 - 01/2018
3	Neoplasm Metastasis (Metastasis) 01/2023 - 04/2011
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2023 - 08/2021
3	Neuroinflammatory Diseases 01/2023 - 12/2017
3	Breast Neoplasms (Breast Cancer) 01/2023 - 12/2014
3	Pigmented Nevus (Melanocytic Nevus) 11/2021 - 06/2005
3	Ischemia 01/2020 - 08/2002
3	Pruritus (Itching) 12/2014 - 04/2013
3	Edema (Dropsy) 07/2014 - 12/2010
2	Multiple Sclerosis 01/2023 - 08/2021

Drug/Important Bio-Agent (IBA)

39	AnkyrinsIBA 10/2023 - 01/2010
27	Calcitonin Gene-Related PeptideIBA 03/2024 - 05/2004
19	TRPA1 Cation ChannelIBA 01/2023 - 08/2008
12	NeuropeptidesIBA 07/2023 - 01/2003
11	Monoclonal AntibodiesIBA 03/2024 - 01/2019
11	Capsaicin (Zostrix)FDA Link 01/2023 - 04/2004
10	Ion Channels (Ion Channel)IBA 10/2023 - 02/2007
9	Peptides (Polypeptides)IBA 07/2023 - 08/2002
8	Analgesics (Analgesic Drugs)IBA 01/2023 - 07/2007
8	Substance PIBA 01/2023 - 05/2004
8	Irritants (Vesicants)IBA 05/2014 - 08/2006
7	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 08/2007
7	2- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamideIBA 01/2019 - 07/2011
6	AntioxidantsIBA 04/2023 - 04/2012
6	Type A Botulinum Toxins (Botox)FDA Link 01/2023 - 07/2007
6	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 11/2021 - 11/2013
6	salicylhydroxamic acid (SHAM)IBA 01/2019 - 01/2016
5	fremanezumabIBA 03/2024 - 11/2021
5	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 07/2023 - 04/2005
5	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 04/2023 - 02/2009
5	Ethanol (Ethyl Alcohol)IBA 04/2023 - 06/2004
5	PAR-2 ReceptorIBA 01/2023 - 11/2002
5	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 11/2021 - 08/2007
5	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2020 - 04/2011
5	Peptide Hydrolases (Proteases)FDA Link 06/2009 - 08/2002
5	TRPV Cation ChannelsIBA 11/2006 - 04/2004
4	galcanezumabIBA 11/2023 - 01/2022
4	AcetaldehydeIBA 04/2023 - 06/2004
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2023 - 01/2002
4	AntibodiesIBA 01/2023 - 09/2006
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2005
4	Thioctic Acid (Lipoic Acid)IBA 01/2020 - 05/2013
4	CationsIBA 01/2019 - 05/2004
4	SmokeIBA 02/2012 - 11/2007
4	Acrolein (Aqualin)IBA 01/2012 - 08/2007
3	erenumabIBA 11/2023 - 01/2022
3	Opioid Analgesics (Opioids)IBA 07/2023 - 01/2009
3	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 04/2023 - 12/2019
3	allyl isothiocyanateIBA 01/2023 - 05/2013
3	Macrophage Colony-Stimulating FactorIBA 01/2023 - 01/2021
3	CalciumIBA 11/2021 - 01/2002
3	Propranolol (Inderal)FDA LinkGeneric 01/2020 - 01/2018
3	Dinoprostone (PGE2)FDA Link 02/2019 - 07/2015
3	Pain-FreeIBA 11/2018 - 01/2018
3	Formaldehyde (Formol)FDA Link 11/2017 - 02/2012
3	Bortezomib (Velcade)FDA Link 01/2017 - 05/2013
3	TachykininsIBA 01/2014 - 10/2005
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2013 - 07/2011
3	resiniferatoxinIBA 02/2009 - 02/2005
3	AldehydesIBA 07/2008 - 08/2007
3	TrypsinIBA 08/2006 - 08/2002
3	Tryptases (Tryptase)IBA 10/2005 - 11/2002
2	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 07/2023 - 02/2019
2	Islet Amyloid PolypeptideIBA 07/2023 - 02/2019
2	Adenylyl Cyclases (Adenylyl Cyclase)IBA 07/2023 - 02/2019
2	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 07/2023 - 02/2019
2	AdrenomedullinIBA 07/2023 - 02/2019
2	olcegepantIBA 04/2023 - 02/2009
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2023 - 11/2015
2	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2023 - 01/2018
2	Freund's AdjuvantIBA 01/2023 - 11/2017
2	Oxygen (Dioxygen)IBA 01/2023 - 01/2018
2	Type C PhospholipasesIBA 01/2023 - 08/2007
2	2,3,4-tri-O-acetylarabinopyranosyl isothiocyanate (AITC)IBA 01/2023 - 01/2017
2	ProstaglandinsIBA 01/2023 - 08/2006
2	N-acetyl-4-benzoquinoneimine (NAPQI)IBA 01/2023 - 12/2010
2	AcetoneIBA 07/2022 - 10/2010
2	Tryptamines (Triptans)IBA 01/2022 - 10/2010

Therapy/Procedure

14	Therapeutics 10/2023 - 06/2006
6	Ligation 01/2023 - 10/2010
5	Vagus Nerve Stimulation 01/2019 - 01/2018
4	Drug Therapy (Chemotherapy) 04/2022 - 05/2013
2	Retreatment 01/2022 - 12/2017